Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer ...

Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Use of teduglutide appeared safe for patients with short bowel syndrome, with no increased incidence of gastrointestinal ...

CFL.ca's Vicki Hall recaps the story of how all six playoff-bound teams journeyed from training camp to the promised land.

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

The SpringWatch presenter revealed he was forced to undergo an invasive procedure at the hospital after he noticed something ...

The group of digestive tract (or gastrointestinal) cancers, which encompasses tumours of the esophagus, stomach, small bowel, ...

Joe and Teresa Graedon of The People's Pharmacy also hear from a reader concerned about their proton pump inhibitor causing depression and memory issues.

Doctor Punam Krishan has issued a warning to anyone taking proton pump inhibitors like omeprazole for acid reflux ...

A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.

Ewing sarcoma is one of the most common types of bone cancer found in children and teenagers. When the cancer spreads to ...